Answers are grounded in this paper and cite their sources.
Background and Hypothesis Urea accumulated in CKD patients` blood can spontaneously decompose into reactive isocyanate and bind to plasma proteins in a reaction called carbamylation. Recent studies suggest a direct link between protein carbamylation and the pathogenesis of cardiovascular events and mortality in dialysis patients. We investigated whether carbamylation of albumin (C-Alb) is associated with increased mortality, major adverse cardiovascular events and need for dialysis in older patients with advanced CKD. Methods The European Quality Study (EQUAL) is a multicentre prospective cohort study. CKD patients aged 65 or older with advanced CKD (eGFR ≤ 20 ml/min/1.73m²) not on kidney replacement therapy were followed up for five years. In a subgroup of 1117 patients, C-Alb was measured at baseline using combined liquid chromatography and mass spectrometry. Multivariable analyses were adjusted for important confounders. Results Mean C-Alb was 13.5 ± 6.5 mmol/mol. Men had higher C-Alb values than women, as well as patients with chronic heart failure compared to patients without. C-Alb correlated positively with age, creatinine, urea, and negatively with eGFR, but not with total albumin. Each unit increase of log-transformed C-Alb was associated with increased risk of overall mortality (adj. HR 1.92, 95%CI 1.40–2.64) and start of dialysis therapy (adj. HR 1.59, 95%CI 1.21–2.09). Conclusion In older advanced CKD patients not on dialysis, increased levels of C-Alb were associated with higher mortality and need for dialysis.
No takes yet. Share an insight, caveat, or question.
Folttmann et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: